UB Paderborn / Katalog / Suche / in CDI

Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro

Pharmacological research, 2007-09, Vol.56 (3), p.248-253

2007

Link zum Volltext

Verfügbarkeit prüfen

DNA Damage Induced by Temozolomide Signals to both ATM and ATR: Role of the Mismatch Repair System

Molecular pharmacology, 2004-09, Vol.66 (3), p.478-491

2004

Link zum Volltext

Verfügbarkeit prüfen

International Profile

Clinical pharmacology and therapeutics, 2016-04, Vol.99 (4), p.348-349

2016

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis

Molecular pharmacology, 1998-08, Vol.54 (2), p.334-341

1998

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line

Journal of chemotherapy (Florence), 2020-01, Vol.32 (1), p.30-40

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?

Pharmacological research, 2018-05, Vol.131, p.1-6

2018

Link zum Volltext

Verfügbarkeit prüfen

Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience

Investigational new drugs, 2006-03, Vol.24 (2), p.99-110

2006

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125

Biochemical pharmacology, 2012-09, Vol.84 (5), p.598-611

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase

The Journal of pharmacology and experimental therapeutics, 1998-05, Vol.285 (2), p.884

1998

Link zum Volltext

Verfügbarkeit prüfen

The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound

Pharmacological research, 2010-05, Vol.61 (5), p.437-448

2010

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic activity of Hypericum perforatum L. on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin

Phytotherapy research, 2004-01, Vol.18 (1), p.66-72

2004

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced increase of carcinoembryonic antigen expression in cancer cells

Pharmacological research, 2004-05, Vol.49 (5), p.383-396

2004

Link zum Volltext

Verfügbarkeit prüfen

Combined effects of protein kinase inhibitors and 5-fluorouracil on CEA expression in human colon cancer cells

Pharmacological research, 2005-08, Vol.52 (2), p.167-173

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components

Cancer chemotherapy and pharmacology, 2001-04, Vol.47 (4), p.361-369

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical applications of telomerase in cancer treatment

Drug resistance updates, 2000-06, Vol.3 (3), p.161-170

2000

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies with staurosporine

International immunopharmacology, 2002-04, Vol.2 (5), p.641-651

2002

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of resistance to N-[5-[ N-(3, 4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)- N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line

Biochemical pharmacology, 1995-07, Vol.50 (3), p.391-398

1995

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: effect of 5-fluorouracil

The Journal of pharmacology and experimental therapeutics, 1996-12, Vol.279 (3), p.1574

1996

Link zum Volltext

Verfügbarkeit prüfen

Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen

Life sciences (1973), 1998-08, Vol.63 (12), p.985-994

1998

Link zum Volltext

Verfügbarkeit prüfen

An immunopharmacological approach for prevention of retrovirus-associated disease in human pathology

Pharmacological research, 1990-11, Vol.22 (6), p.645-659

1990

Link zum Volltext

Verfügbarkeit prüfen

In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds

Cancer chemotherapy and pharmacology, 1997, Vol.40 (2), p.180-184

1997

Link zum Volltext

Verfügbarkeit prüfen

Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes

International journal of immunopharmacology, 1994-07, Vol.16 (7), p.569-579

1994

Link zum Volltext

Verfügbarkeit prüfen

Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells

Immunopharmacology, 1991-05, Vol.21 (3), p.199-210

1991

Link zum Volltext

Verfügbarkeit prüfen

Natural resistance if mice pretreated with 5-(3,3′-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells

International journal of immunopharmacology, 1984, Vol.6 (4), p.251-258

1984

Link zum Volltext

Verfügbarkeit prüfen

Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition

Chemotherapy (Basel), 1975, Vol.21 (6), p.321

1975

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro

DNA Damage Induced by Temozolomide Signals to both ATM and ATR: Role of the Mismatch Repair System

International Profile

Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis

Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line

Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?

Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience

Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125

Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase

The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound

Cytotoxic activity of Hypericum perforatum L. on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin

Drug-induced increase of carcinoembryonic antigen expression in cancer cells

Combined effects of protein kinase inhibitors and 5-fluorouracil on CEA expression in human colon cancer cells

Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components

Clinical applications of telomerase in cancer treatment

Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies with staurosporine

Mechanisms of resistance to N-[5-[ N-(3, 4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)- N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line

Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: effect of 5-fluorouracil

Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen

An immunopharmacological approach for prevention of retrovirus-associated disease in human pathology

In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds

Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes

Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells

Natural resistance if mice pretreated with 5-(3,3′-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells

Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition

Aktive Filter

Suchergebnisse filtern